Sign In
Buy PRLB
Proto Labs Earnings Calls
| Release date | May 01, 2026 |
| EPS estimate | $0.400 |
| EPS actual | $0.540 |
| EPS Surprise | 35.00% |
| Revenue estimate | 135.309M |
| Revenue actual | 139.336M |
| Revenue Surprise | 2.98% |
| Release date | Feb 06, 2026 |
| EPS estimate | $0.350 |
| EPS actual | $0.440 |
| EPS Surprise | 25.71% |
| Revenue estimate | 128.993M |
| Revenue actual | 136.493M |
| Revenue Surprise | 5.81% |
| Release date | Oct 31, 2025 |
| EPS estimate | $0.390 |
| EPS actual | $0.470 |
| EPS Surprise | 20.51% |
| Revenue estimate | 129.071M |
| Revenue actual | 135.366M |
| Revenue Surprise | 4.88% |
| Release date | Jul 31, 2025 |
| EPS estimate | $0.330 |
| EPS actual | $0.410 |
| EPS Surprise | 24.24% |
| Revenue estimate | 132.085M |
| Revenue actual | 135.063M |
| Revenue Surprise | 2.25% |
Last 4 Quarters for Proto Labs
Below you can see how PRLB performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 31, 2025 |
| Price on release | $43.12 |
| EPS estimate | $0.330 |
| EPS actual | $0.410 |
| EPS surprise | 24.24% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $39.11 |
| Jul 28, 2025 | $39.64 |
| Jul 29, 2025 | $40.02 |
| Jul 30, 2025 | $39.23 |
| Jul 31, 2025 | $43.12 |
| Aug 01, 2025 | $43.19 |
| Aug 04, 2025 | $43.35 |
| Aug 05, 2025 | $44.20 |
| Aug 06, 2025 | $44.96 |
| 4 days before | 10.25% |
| 4 days after | 4.27% |
| On release day | 0.162% |
| Change in period | 14.96% |
| Release date | Oct 31, 2025 |
| Price on release | $49.76 |
| EPS estimate | $0.390 |
| EPS actual | $0.470 |
| EPS surprise | 20.51% |
| Date | Price |
|---|---|
| Oct 27, 2025 | $54.35 |
| Oct 28, 2025 | $53.49 |
| Oct 29, 2025 | $52.67 |
| Oct 30, 2025 | $53.03 |
| Oct 31, 2025 | $49.76 |
| Nov 03, 2025 | $53.47 |
| Nov 04, 2025 | $48.28 |
| Nov 05, 2025 | $49.80 |
| Nov 06, 2025 | $48.64 |
| 4 days before | -8.45% |
| 4 days after | -2.25% |
| On release day | 7.46% |
| Change in period | -10.51% |
| Release date | Feb 06, 2026 |
| Price on release | $67.17 |
| EPS estimate | $0.350 |
| EPS actual | $0.440 |
| EPS surprise | 25.71% |
| Date | Price |
|---|---|
| Feb 02, 2026 | $53.45 |
| Feb 03, 2026 | $53.67 |
| Feb 04, 2026 | $53.46 |
| Feb 05, 2026 | $52.48 |
| Feb 06, 2026 | $67.17 |
| Feb 09, 2026 | $65.91 |
| Feb 10, 2026 | $66.35 |
| Feb 11, 2026 | $67.15 |
| Feb 12, 2026 | $66.45 |
| 4 days before | 25.67% |
| 4 days after | -1.07% |
| On release day | -1.88% |
| Change in period | 24.32% |
| Release date | May 01, 2026 |
| Price on release | $65.17 |
| EPS estimate | $0.400 |
| EPS actual | $0.540 |
| EPS surprise | 35.00% |
| Date | Price |
|---|---|
| Apr 27, 2026 | $63.79 |
| Apr 28, 2026 | $63.68 |
| Apr 29, 2026 | $62.26 |
| Apr 30, 2026 | $64.81 |
| May 01, 2026 | $65.17 |
| May 04, 2026 | $64.34 |
| May 05, 2026 | $67.69 |
| May 06, 2026 | $68.89 |
| May 07, 2026 | $68.06 |
| 4 days before | 2.16% |
| 4 days after | 4.43% |
| On release day | -1.27% |
| Change in period | 6.69% |
Proto Labs Earnings Call Transcript Summary of Q1 2026
Proto Labs reported a strong start to 2026 with record Q1 revenue of $139.3M, up 10.4% year-over-year (8.7% constant currency). Key drivers were robust CNC machining demand (Q1 machining +17.6% CC; U.S. machining +23% YoY), higher revenue per customer (+20% YoY) from larger strategic accounts (notably aerospace & defense, space, satellites, drones, robotics), and improving European performance (Q1 Europe +11% sequential). Non-GAAP gross margin expanded to 46.2% (+140 bps YoY and sequentially) and adjusted EBITDA increased to $22.8M (16.3% of revenue). Non-GAAP EPS was $0.54, the highest since Q3 2020. Cash from operations was $17.5M; cash & investments were $158M with zero debt. Management reiterated full-year 2026 revenue guidance of +6% to +8% and Q2 revenue guidance of $140M–$148M (implied ~7% YoY at midpoint). Operational initiatives include combining product & tech under CT AIO, hiring a Head of Business Excellence Systems to drive continuous improvement, establishing a Global Capability Center in India, and a strategic reset in Europe (cost reductions and go-to-market realignment). Management plans continued investment in R&D, software and capacity (adding CNC and DMLS machines) while preserving disciplined cost control; they expect OpEx to increase through the year to fund strategic priorities, with full-year gross margin expected to be slightly up on 2025.
